Abstract
We describe a patient who developed daptomycin-resistant, methicillin-resistant Staphylococcus aureus (MRSA) during an episode of presumed septic thrombophlebitis of the portal vein. Although daptomycin is an alternative agent for treatment of drug-resistant gram-positive bacterial infections, development of resistance during prolonged use may occur with MRSA bacteremia from a persistent focus. © 2005 by the Infectious Diseases Society of America. All rights reserved.
Cite
CITATION STYLE
Mangili, A., Bica, I., Snydman, D. R., & Hamer, D. H. (2005). Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia. Clinical Infectious Diseases, 40(7), 1058–1060. https://doi.org/10.1086/428616
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
